newsfilter
← Latest News
Business Wire·

First in Asia to Develop Liver Cancer Registry Through Collaborations Among National Cancer Centre Singapore, Singapore Clinical Research Institute and IMS Health

SINGAPORE--(BUSINESS WIRE)--National Cancer Centre Singapore (NCCS), Singapore Clinical Research Institute (SCRI) and IMS Health (NYSE:IMS) will collaborate to develop its first Liver Cancer or Hepatocellular Carcinoma (HCC) Registry in Asia through the Asian HCC Physician Network.